Quality Systems Approach Is Key To Transforming FDA – Crawford
This article was originally published in The Rose Sheet
Executive Summary
Capitalizing on information technology advances and regulatory process innovations are key factors in creating new vision for FDA, commissioner nominee Lester Crawford, DVM/PhD, said during a March 17 Senate Health Committee hearing on his nomination
You may also be interested in...
Crawford’s White House Valentine Enclosed With FDA Nomination
FDA Acting Commissioner Lester Crawford, PhD/DVM, has been nominated to fill the position permanently, the White House announced Feb. 14
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle